Cite
Circulating matrix γ-carboxyglutamate protein (MGP) species are refractory to vitamin K treatment in a new case of Keutel syndrome.
MLA
Cranenburg, E. C. M., et al. “Circulating Matrix γ-Carboxyglutamate Protein (MGP) Species Are Refractory to Vitamin K Treatment in a New Case of Keutel Syndrome.” Journal of Thrombosis and Haemostasis : JTH, vol. 9, no. 6, June 2011, pp. 1225–35. EBSCOhost, https://doi.org/10.1111/j.1538-7836.2011.04263.x.
APA
Cranenburg, E. C. M., VAN Spaendonck-Zwarts, K. Y., Bonafe, L., Mittaz Crettol, L., Rödiger, L. A., Dikkers, F. G., VAN Essen, A. J., Superti-Furga, A., Alexandrakis, E., Vermeer, C., Schurgers, L. J., & Laverman, G. D. (2011). Circulating matrix γ-carboxyglutamate protein (MGP) species are refractory to vitamin K treatment in a new case of Keutel syndrome. Journal of Thrombosis and Haemostasis : JTH, 9(6), 1225–1235. https://doi.org/10.1111/j.1538-7836.2011.04263.x
Chicago
Cranenburg, E C M, K Y VAN Spaendonck-Zwarts, L Bonafe, L Mittaz Crettol, L A Rödiger, F G Dikkers, A J VAN Essen, et al. 2011. “Circulating Matrix γ-Carboxyglutamate Protein (MGP) Species Are Refractory to Vitamin K Treatment in a New Case of Keutel Syndrome.” Journal of Thrombosis and Haemostasis : JTH 9 (6): 1225–35. doi:10.1111/j.1538-7836.2011.04263.x.